316 related articles for article (PubMed ID: 33844027)
1. Nrf2 as a potential target for Parkinson's disease therapy.
Niu Y; Zhang J; Dong M
J Mol Med (Berl); 2021 Jul; 99(7):917-931. PubMed ID: 33844027
[TBL] [Abstract][Full Text] [Related]
2. The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease.
Chakkittukandiyil A; Sajini DV; Karuppaiah A; Selvaraj D
Neurochem Int; 2022 Jun; 156():105325. PubMed ID: 35278519
[TBL] [Abstract][Full Text] [Related]
3. Shaping the Nrf2-ARE-related pathways in Alzheimer's and Parkinson's diseases.
Fão L; Mota SI; Rego AC
Ageing Res Rev; 2019 Sep; 54():100942. PubMed ID: 31415806
[TBL] [Abstract][Full Text] [Related]
4. Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model.
Kim S; Indu Viswanath AN; Park JH; Lee HE; Park AY; Choi JW; Kim HJ; Londhe AM; Jang BK; Lee J; Hwang H; Lim SM; Pae AN; Park KD
Neuropharmacology; 2020 May; 167():107989. PubMed ID: 32032607
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective Effect of Phloretin in Rotenone-Induced Mice Model of Parkinson's Disease: Modulating mTOR-NRF2-p62 Mediated Autophagy-Oxidative Stress Crosstalk.
Shirgadwar SM; Kumar R; Preeti K; Khatri DK; Singh SB
J Alzheimers Dis; 2023; 94(s1):S109-S124. PubMed ID: 36463449
[TBL] [Abstract][Full Text] [Related]
6. Ellagic acid activates the Keap1-Nrf2-ARE signaling pathway in improving Parkinson's disease: A review.
Wang Q; Botchway BOA; Zhang Y; Liu X
Biomed Pharmacother; 2022 Dec; 156():113848. PubMed ID: 36242848
[TBL] [Abstract][Full Text] [Related]
7. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1).
Bresciani A; Missineo A; Gallo M; Cerretani M; Fezzardi P; Tomei L; Cicero DO; Altamura S; Santoprete A; Ingenito R; Bianchi E; Pacifici R; Dominguez C; Munoz-Sanjuan I; Harper S; Toledo-Sherman L; Park LC
Arch Biochem Biophys; 2017 Oct; 631():31-41. PubMed ID: 28801166
[TBL] [Abstract][Full Text] [Related]
8. Bruceine D elevates Nrf2 activation to restrain Parkinson's disease in mice through suppressing oxidative stress and inflammatory response.
Yang Y; Kong F; Ding Q; Cai Y; Hao Y; Tang B
Biochem Biophys Res Commun; 2020 Jun; 526(4):1013-1020. PubMed ID: 32321640
[TBL] [Abstract][Full Text] [Related]
9. Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death.
Kumar H; Koppula S; Kim IS; More SV; Kim BW; Choi DK
CNS Neurol Disord Drug Targets; 2012 Dec; 11(8):1015-29. PubMed ID: 23244425
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson's Disease.
Wang Y; Gao L; Chen J; Li Q; Huo L; Wang Y; Wang H; Du J
Front Pharmacol; 2021; 12():757161. PubMed ID: 34887759
[TBL] [Abstract][Full Text] [Related]
11. Safranal prevents rotenone-induced oxidative stress and apoptosis in an in vitro model of Parkinson's disease through regulating Keap1/Nrf2 signaling pathway.
Pan PK; Qiao LY; Wen XN
Cell Mol Biol (Noisy-le-grand); 2016 Dec; 62(14):11-17. PubMed ID: 28145852
[TBL] [Abstract][Full Text] [Related]
12. Activation of p62-Keap1-Nrf2 Pathway Protects 6-Hydroxydopamine-Induced Ferroptosis in Dopaminergic Cells.
Sun Y; He L; Wang T; Hua W; Qin H; Wang J; Wang L; Gu W; Li T; Li N; Liu X; Chen F; Tang L
Mol Neurobiol; 2020 Nov; 57(11):4628-4641. PubMed ID: 32770451
[TBL] [Abstract][Full Text] [Related]
13. Isoflavone biochanin A, a novel nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element activator, protects against oxidative damage in HepG2 cells.
Liang F; Cao W; Huang Y; Fang Y; Cheng Y; Pan S; Xu X
Biofactors; 2019 Jul; 45(4):563-574. PubMed ID: 31131946
[TBL] [Abstract][Full Text] [Related]
14. NF-κB and Keap1 Interaction Represses Nrf2-Mediated Antioxidant Response in Rabbit Hemorrhagic Disease Virus Infection.
Hu B; Wei H; Song Y; Chen M; Fan Z; Qiu R; Zhu W; Xu W; Wang F
J Virol; 2020 May; 94(10):. PubMed ID: 32161178
[TBL] [Abstract][Full Text] [Related]
15. Sulforaphane Ameliorates 3-Nitropropionic Acid-Induced Striatal Toxicity by Activating the Keap1-Nrf2-ARE Pathway and Inhibiting the MAPKs and NF-κB Pathways.
Jang M; Cho IH
Mol Neurobiol; 2016 May; 53(4):2619-35. PubMed ID: 26096705
[TBL] [Abstract][Full Text] [Related]
16. Tricetin protects against 6-OHDA-induced neurotoxicity in Parkinson's disease model by activating Nrf2/HO-1 signaling pathway and preventing mitochondria-dependent apoptosis pathway.
Ren J; Yuan L; Wang W; Zhang M; Wang Q; Li S; Zhang L; Hu K
Toxicol Appl Pharmacol; 2019 Sep; 378():114617. PubMed ID: 31176653
[TBL] [Abstract][Full Text] [Related]
17. The Keap1-Nrf2 System: A Mediator between Oxidative Stress and Aging.
Yu C; Xiao JH
Oxid Med Cell Longev; 2021; 2021():6635460. PubMed ID: 34012501
[TBL] [Abstract][Full Text] [Related]
18. Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson's disease.
Barone MC; Sykiotis GP; Bohmann D
Dis Model Mech; 2011 Sep; 4(5):701-7. PubMed ID: 21719443
[TBL] [Abstract][Full Text] [Related]
19. Role of microgliosis, oxidative stress and associated neuroinflammation in the pathogenesis of Parkinson's disease: The therapeutic role of Nrf2 activators.
Jayaram S; Krishnamurthy PT
Neurochem Int; 2021 May; 145():105014. PubMed ID: 33689805
[TBL] [Abstract][Full Text] [Related]
20. The role of Nrf2 and PPARgamma in the improvement of oxidative stress in hypertension and cardiovascular diseases.
Dovinova I; Kvandová M; Balis P; Gresova L; Majzunova M; Horakova L; Chan JY; Barancik M
Physiol Res; 2020 Dec; 69(Suppl 4):S541-S553. PubMed ID: 33656904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
